BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 1662639)

  • 1. Toxic shock syndrome and tampons.
    Schuchat A; Broome CV
    Epidemiol Rev; 1991; 13():99-112. PubMed ID: 1662639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production
    Nonfoux L; Chiaruzzi M; Badiou C; Baude J; Tristan A; Thioulouse J; Muller D; Prigent-Combaret C; Lina G
    Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29678918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device-Associated Menstrual Toxic Shock Syndrome.
    Schlievert PM; Davis CC
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32461307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic shock syndrome: a multisystem conundrum.
    Arbuthnott JP
    Microbiol Sci; 1988 Jan; 5(1):13-6. PubMed ID: 3079212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.
    Schlievert PM
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):31-38. PubMed ID: 31853743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frequency of toxic-shock-syndrome-toxin producing strains of Staphylococcus aureus in the Basel region].
    Vischer WA; Stalder H; Faupel DM
    Schweiz Med Wochenschr; 1985 Aug; 115(35):1196-9. PubMed ID: 4048915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Special features of intensive care of toxic shock syndrome. Review and case report of a TSST-1 associated toxic-shock syndrome with adult respiratory distress syndrome and multiple organ failure from a staphylococcal panaritium].
    Lang C; Behnke H; Bittersohl J; Eberhart L; Walthers E; Sommer F; Wulf H; Geldner G
    Anaesthesist; 2003 Sep; 52(9):805-13. PubMed ID: 14504808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cases of menstrual toxic shock syndrome in the Czech Republic in 1997-2011].
    Petrás P; Machová I; Rysková L; Prásil P
    Epidemiol Mikrobiol Imunol; 2011 Nov; 60(4):161-6. PubMed ID: 22324245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal tampon model for toxic shock syndrome.
    Melish ME; Murata S; Fukunaga C; Frogner K; McKissick C
    Rev Infect Dis; 1989; 11 Suppl 1():S238-46; discussion S246-7. PubMed ID: 2928642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic shock syndrome in Britain--epidemiology and microbiology.
    de Saxe MJ; Hawtin P; Wieneke AA
    Postgrad Med J; 1985; 61 Suppl 1():5-21. PubMed ID: 4059160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcus aureus exotoxins are present in vivo in tampons.
    Schlievert PM; Nemeth KA; Davis CC; Peterson ML; Jones BE
    Clin Vaccine Immunol; 2010 May; 17(5):722-7. PubMed ID: 20335433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for development of toxic shock syndrome. Association with a tampon brand.
    Schlech WF; Shands KN; Reingold AL; Dan BB; Schmid GP; Hargrett NT; Hightower A; Herwaldt LA; Neill MA; Band JD; Bennett JV
    JAMA; 1982 Aug; 248(7):835-9. PubMed ID: 7097945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of toxic shock syndrome: the need for education still exists.
    Colbry SL
    Nurse Pract; 1992 Sep; 17(9):39-40, 43, 46. PubMed ID: 1328970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in Staphylococcus aureus growth and exotoxin production and in vaginal interleukin 8 levels due to glycerol monolaurate in tampons.
    Strandberg KL; Peterson ML; Schaefers MM; Case LC; Pack MC; Chase DJ; Schlievert PM
    Clin Infect Dis; 2009 Dec; 49(11):1711-7. PubMed ID: 19863450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic shock syndrome in Canada.
    Clayton AJ; Peacocke JE; Ewan PE
    Can Med Assoc J; 1982 Apr; 126(7):776-9. PubMed ID: 7042059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menstrual toxic shock syndrome: case report and systematic review of the literature.
    Berger S; Kunerl A; Wasmuth S; Tierno P; Wagner K; Brügger J
    Lancet Infect Dis; 2019 Sep; 19(9):e313-e321. PubMed ID: 31151811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic shock syndrome: an update.
    Reingold AL
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1236-9. PubMed ID: 1951580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation by improved syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
    Wong AC; Downs SA
    J Clin Microbiol; 1989 Nov; 27(11):2482-7. PubMed ID: 2808672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic Shock Syndrome: Still a Timely Diagnosis.
    Gossack-Keenan KL; Kam AJ
    Pediatr Emerg Care; 2020 Mar; 36(3):e163-e165. PubMed ID: 29040243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcal toxic shock syndrome: still a problem.
    Schlievert PM
    Med J Aust; 2005 Jun; 182(12):651-2. PubMed ID: 16116687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.